Will Ginkgo Bioworks become “the Amazon” of Synthetic Biology?
The founder, Jason Kelly, certainly thinks so.
Ginkgo Bioworks (NYSE: DNA), has big partnerships with companies like Moderna and Bayer, among many other prominent names.
They’ve also received funding from the likes of the Bill & Melinda Gates Foundation (though it’s just a very modest $2 million or so, a far cry from the vast sums they dumped into Moderna).
https://technologyreview.com/2021/08/24/1032308/is-ginkgos-synthetic-biology-story-worth-15-billion/
